生产企业：AusperBio Therapeutics, Inc., Ausper Biopharma Co., Ltd.
AusperBio's lead investigational unconjugated antisense oligonucleotide (ASO) therapy for chronic hepatitis B (CHB).
AusperBio's lead investigational unconjugated antisense oligonucleotide (ASO) therapy for chronic hepatitis B (CHB).
Suppresses hepatitis B surface antigen (HBsAg) production, inhibits viral DNA replication, and promotes immune reactivation, with the goal of achieving a functional cure for chronic hepatitis B (CHB).
chronic hepatitis B (CHB)
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
